BackSAB Biotherapeutics- Warrants (25/07/2027) Overview

SAB Biotherapeutics- Warrants (25/07/2027) Inventory

Latest inventory for SABSW: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer average

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Inventory History

Loading

SAB Biotherapeutics- Warrants (25/07/2027) vs. peers: Inventory Comparison

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) FAQ

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) currently reports a inventory of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore SAB Biotherapeutics- Warrants (25/07/2027)'s inventory history and peer comparisons.

SAB Biotherapeutics- Warrants (25/07/2027)'s inventory changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics- Warrants (25/07/2027) reported $0 in inventory as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics- Warrants (25/07/2027), and consider following SABSW for alerts when major investors trade the stock.